Intrathymic pathogenesis and dual genetic control of myasthenia gravis.
We propose a two-step model for the pathogenesis of myasthenia gravis. In the first step, primitive intrathymic stem-cells are induced by abnormal stimuli to differentiate to (abnormal?) myogenic cells. In the second step, immunocompetent T lymphocytes start an autoimmune reaction against these newly differentiated myogenic cells. The clinical stage is reached when autosensitised effector T lymphocytes leave the thymus and either infiltrate the synaptic spaces of peripheral muscles or participate in the formation of autoantibodies, causing the neuromuscular symptoms. At two points the pathogenesis is under genetic control--the first at the differentiation of the stem-cells to myogenic cells and the second at the immune responsiveness of the lymphocytes to these atypical intrathymic muscle cells.
D000818:Animals; D000917:Antibody Formation; D000937:Antigen-Antibody Reactions; D001323:Autoantibodies; D001324:Autoantigens; D001327:Autoimmune Diseases; D002454:Cell Differentiation; D002999:Clone Cells; D046508:Culture Techniques; D005809:Genes, Regulator; D006680:HLA Antigens; D006412:Hematopoietic Stem Cells / Q000473:pathology; D051379:Mice; D009132:Muscles / Q000276:immunology / Q000473:pathology; D009157:Myasthenia Gravis / Q000209:etiology* / Q000235:genetics; D051381:Rats; D013601:T-Lymphocytes / Q000276:immunology; D013950:Thymus Gland / Q000473:pathology
D001323:Autoantibodies; D001324:Autoantigens; D006680:HLA Antigens